Escalon Medical Corp.
Cash Flow Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $4.0M | $105.5K | $-125.3K | $456.8K | $18.1K | $-52.0K | $-650.3K | $-250.0K |
| Depreciation & Amortization | $22.6K | $37.8K | $46.0K | $45.2K | $48.4K | $44.8K | $50.1K | $50.1K |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | — | — | — | — | — | — | — | — |
| Net Cash from Operating Activities | $-402.6K | $380.7K | $-602.8K | $325.1K | $-1.0M | $838.7K | $-168.5K | $-472.7K |
| Investing Activities | ||||||||
| Capital Expenditures | $4.4K | $3.9K | $40.3K | $6.7K | $0 | $9.4K | $59.8K | $22.1K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $2.8M | $-3.9K | $-40.3K | $-13.8K | $0 | $-9.4K | $-59.8K | $-22.1K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $-129.9K | $-39.9K | $-37.5K | $-15.4K | $-6.9K | $-3.7K | $646.6K | $33.7K |
| Net Change in Cash | $2.3M | $336.9K | $-680.5K | $295.9K | $-1.1M | $825.7K | $418.4K | $-461.1K |
| Free Cash Flow | $-407.0K | $376.8K | $-643.1K | $318.5K | $-1.0M | $829.3K | $-228.2K | $-494.8K |